37. Meet-the-Professor: Outpatient Antibiotic Therapy to Address Preventable Hospitalizations
Session: Meet-the-Professor Session: Outpatient Antibiotic Therapy to Address Preventable Hospitalizations
Thursday, October 3, 2013: 7:00 AM
Room: The Moscone Center: 250-262
David Talan, MD, FIDSA, Emergency Medicine/Infectious Diseases, University of California Los Angeles Medical Center, Sylmar, CA

Dr. Talan received his medical degree from the University of Illinois Medical College in Chicago. He completed his residencies in Internal and Emergency Medicine and fellowship in Infectious Diseases at the University of California Los Angeles (UCLA) and its associated medical centers. He is board certified in Internal Medicine, Emergency Medicine, and Infectious Diseases. Since 1993, Dr. Talan has been Chairman of the Olive View-UCLA Department of Emergency Medicine. He is also faculty in the Division of Infectious Diseases at Olive View-UCLA Medical Center. He is Professor of Medicine in Residence at The David Geffen School of Medicine at UCLA. He is a Fellow of the American College of Emergency Physicians and the Infectious Diseases Society of America. Dr. Talan serves on the editorial boards of the Annals of Emergency Medicine, Emergency Medicine News, and Pediatric Emergency Care and is a reviewer for many journals including Clinical Infectious Diseases, JAMA, and The Medical Letter. Dr. Talan is considered an authority in the area of acute infections that result in severe morbidity and death, and, along with his colleagues and trainees, has established Olive View-UCLA as a center of excellence in acute infectious diseases research and education. His research focuses on emergency department-based surveillance and epidemiological research of emerging infections and clinical investigations of acute infectious diseases. He has investigated skin and soft tissue infections, animal and human bites, rabies, tetanus, pneumonia, pyelonephritis, meningitis, and sepsis. Dr. Talan has several publications in JAMA and the New England Journal of Medicine, including the seminal research on the emergence of community associated-MRSA in patients with skin and soft tissue infections. He edited and authored the Infectious Diseases Clinics of North America edition on infectious disease emergences. He is principal investigator of a CDC-supported emergency department-based national sentinel network for research on emerging infectious diseases in the United States called EMERGEncy ID NET, which was established in 1995. He is also co-principal investigator of an NIH contract to study off patent antibiotics to treat skin and soft tissue infections caused by community-associated MRSA called STOP MRSA. In 1988, Dr. Talan established the Olive View-UCLA National Conferences on Advances in Emergency Medicine, which for 24 consecutive years provided CME to practicing emergency physicians with an emphasis on infectious diseases education. He has also been invited to lecture nationally and internationally on infectious diseases surveillance and research.



Previous Presentation | Next Presentation >>

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.